Oscillating Positive Expiratory Pressure (OPEP) Devices Market Size (2024 - 2029)

The oscillating positive expiratory pressure (OPEP) devices market is projected to experience growth due to the increasing prevalence of respiratory diseases, which has been exacerbated by the pandemic. The initial surge in demand during the pandemic has stabilized, but the market is expected to expand as new respiratory health challenges emerge. Technological advancements, such as the development of single-use devices to reduce infection risks, are also contributing to market growth. Despite these positive trends, the market's expansion may be impeded by a shortage of skilled professionals.

Market Size of Oscillating Positive Expiratory Pressure (OPEP) Devices Industry

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:
Oscillating Positive Expiratory Pressure Devices Market Summary
Study Period 2021 - 2029
Base Year For Estimation 2023
Forecast Data Period 2024 - 2029
CAGR 5.30 %
Fastest Growing Market Asia Pacific
Largest Market North America

Major Players

Oscillating Positive Expiratory Pressure (OPEP) Devices Market Major Players

*Disclaimer: Major Players sorted in no particular order

setting-icon

Need a report that reflects how COVID-19 has impacted this market and its growth?

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Oscillating Positive Expiratory Pressure Devices Market Analysis

The oscillating positive expiratory pressure (OPEP) devices market is expected to register a CAGR of 5.3% over the forecast period.

The increased number of cases of chronic pulmonary diseases with the outbreak of the pandemic has impacted the market. According to a study published by the ERJ in October 2021, patients with prior influenza were at higher risk of developing severe COVID-19 and had a higher mortality rate than patients without a history of respiratory illness. Similarly, per a study published by the National Center for Biotechnology Information (NCBI) in July 2021, chronic respiratory diseases were common among patients with COVID-19. Increasing cases of respiratory diseases in the initial days of the pandemic propelled the demand for oscillating positive expiratory pressure devices as it is used to clear mucus from the lungs of individuals with respiratory illnesses.

Although there was a sharp rise in demand for OPEP devices initially, it has now reduced greatly now that the pandemic has ended.

However, the OPEP devices market is expected to maintain growth over the forecast period owing to growing cases of other respiratory diseases such as pneumonia and asthma.

For instance, according to a study published by the NCBI in June 2021, chronic respiratory diseases contribute significantly to the national, regional, and global burden of disease. The study also reported that morbidity and mortality from such conditions are estimated to be high in low- and middle-income countries. Similarly, as per the report published by Lung India in December 2021, the prevalence rate of chronic obstructive pulmonary disease (COPD) among males and females was 11.4% in India in 2021. Similarly, as per the ERS journal of 2021, it was estimated that around 36,580,965 Europeans suffered from COPD in 2020 and as per Mordor Intelligence analysis around 49,453,852 Europeans were expected to suffer from COPD in 2050.

Owing to such a high prevalence of COPD the researchers are also focusing on developing innovative and new devices for advanced treatment. For instance, as per another study published by the NCBI in January 2021, due to the increasing cases of COPD across the globe, the researchers were focusing on developing new advanced devices and novel surgical and bronchoscopic procedures. Therefore, such positive advancements and a high prevalence of respiratory diseases are anticipated to propel the demand for OPEP devices, thereby surging market growth.

Furthermore, the technological advancements related to OPEP devices are also pushing market growth. For instance, as per a study published by BMC Pulmonary Medicine in October 2021, currently, reusable OPEP devices are available that require regular cleaning and disinfection to prevent harboring of potentially pathogenic organisms. However, adherence to cleaning regimens for respiratory devices is often critical. Therefore, a prototype single-use OPEP device - 'UL-OPEP' was developed to mitigate the risk of pathogen contamination. Such technological advancements and innovations may create opportunities for the market, which in turn may encourage many new players to enter the market and drive growth.

On the other hand, a lack of skilled professionals is likely to hinder the market growth over the forecast period.

Oscillating Positive Expiratory Pressure Devices Industry Segmentation

An OPEP device refers to a device that uses Oscillating Positive Expiratory Pressure or OPEP to help clear secretions from the airways. People with chronic bronchitis, bronchiectasis, COPD, and cystic fibrosis often produce excessive mucus. As they exhale through the OPEP device, they can feel vibrations or 'pulses,' which loosen the mucus from the walls of the lungs, making it easier to cough up the secretions. The Oscillating Positive Expiratory Pressure (OPEP) Devices market is Segmented by Product Type (Face Mask PEP Devices, Mouthpiece PEP Devices, and Bottle PEP Devices), Indication (COPD and Asthma, Bronchitis, Cystic Fibrosis, and Others), End-User (Hospital and Clinics, Ambulatory Surgical Centers, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World (ROW)). The report offers the value (in USD million) for the above segments.

By Product Type
Face Mask PEP Devices
Mouthpiece PEP Devices
Bottle PEP Devices
By Indication
COPD and Asthma
Bronchitis
Cystic Fibrosis
Others
By End-User
Hospital and Clinics
Ambulatory Surgical Centers
Others
Geography
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Rest of the World (ROW)
Need A Different Region Or Segment?
Customize Now

Oscillating Positive Expiratory Pressure (OPEP) Devices Market Size Summary

The oscillating positive expiratory pressure (OPEP) devices market is poised for steady growth, driven by the increasing prevalence of chronic respiratory diseases such as asthma and COPD. The initial surge in demand during the pandemic, due to the heightened cases of respiratory illnesses, has stabilized but is expected to maintain an upward trajectory. This is attributed to the ongoing need for effective mucus clearance solutions in patients with respiratory conditions. The market is further bolstered by technological advancements, such as the development of single-use OPEP devices to reduce pathogen contamination risks, which may attract new entrants and foster competition. Despite these positive trends, the market faces challenges, including a shortage of skilled professionals, which could impede growth.

North America is anticipated to lead the OPEP devices market, supported by a high incidence of pediatric respiratory diseases and robust research activities. The region's growth is fueled by factors such as the prevalence of asthma among children and the increasing cases of respiratory diseases in adults. The competitive landscape is characterized by the presence of both international and local players, with key companies like Smiths Medical, Inc. and AirPhysio holding significant market shares. Recent product launches and regulatory approvals, such as the acapella choice blue vibratory PEP therapy system and the AirPhysio device, underscore the dynamic nature of the market. These developments, coupled with strategic partnerships and acquisitions, are expected to drive further expansion in the coming years.

Explore More

Oscillating Positive Expiratory Pressure (OPEP) Devices Market Size - Table of Contents

  1. 1. MARKET DYNAMICS

    1. 1.1 Market Overview

    2. 1.2 Market Drivers

      1. 1.2.1 Rising Prevalence of Chronic Respiratory Diseases Across the Globe

      2. 1.2.2 Growing Technological Advancements

    3. 1.3 Market Restraints

      1. 1.3.1 Lack of Skilled Professionals

    4. 1.4 Porter's Five Force Analysis

      1. 1.4.1 Threat of New Entrants

      2. 1.4.2 Bargaining Power of Buyers/Consumers

      3. 1.4.3 Bargaining Power of Suppliers

      4. 1.4.4 Threat of Substitute Products

      5. 1.4.5 Intensity of Competitive Rivalry

  2. 2. MARKET SEGMENTATION (Market Size by Value - USD Million)

    1. 2.1 By Product Type

      1. 2.1.1 Face Mask PEP Devices

      2. 2.1.2 Mouthpiece PEP Devices

      3. 2.1.3 Bottle PEP Devices

    2. 2.2 By Indication

      1. 2.2.1 COPD and Asthma

      2. 2.2.2 Bronchitis

      3. 2.2.3 Cystic Fibrosis

      4. 2.2.4 Others

    3. 2.3 By End-User

      1. 2.3.1 Hospital and Clinics

      2. 2.3.2 Ambulatory Surgical Centers

      3. 2.3.3 Others

    4. 2.4 Geography

      1. 2.4.1 North America

        1. 2.4.1.1 United States

        2. 2.4.1.2 Canada

        3. 2.4.1.3 Mexico

      2. 2.4.2 Europe

        1. 2.4.2.1 Germany

        2. 2.4.2.2 United Kingdom

        3. 2.4.2.3 France

        4. 2.4.2.4 Italy

        5. 2.4.2.5 Spain

        6. 2.4.2.6 Rest of Europe

      3. 2.4.3 Asia-Pacific

        1. 2.4.3.1 China

        2. 2.4.3.2 Japan

        3. 2.4.3.3 India

        4. 2.4.3.4 Australia

        5. 2.4.3.5 South Korea

        6. 2.4.3.6 Rest of Asia-Pacific

      4. 2.4.4 Rest of the World (ROW)

Oscillating Positive Expiratory Pressure (OPEP) Devices Market Size FAQs

The Oscillating Positive Expiratory Pressure (OPEP) Devices Market is projected to register a CAGR of 5.30% during the forecast period (2024-2029)

Smiths Medical, Inc. , Monaghan Medical Corporation , R. Cegla GmbH & Co. KG , PARI GmbH and AirPhysio are the major companies operating in the Oscillating Positive Expiratory Pressure (OPEP) Devices Market.

Oscillating Positive Expiratory Pressure (OPEP) Devices Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)